PharmaSwiss was founded in 2000. A wide portfolio consists of pharmaceutical products that today provide therapy and prevention for the most important health segments, as well as a large number of supplements that are an absolute requirement of the modern consumer. We cover all important therapeutic areas with our medicines.
Innovation in production and security in quality are the key words of PharmaSwiss' development and business.
Since 2011, we have been operating as part of the Canadian corporation Valeant, one of the fastest growing generic companies in the global pharmaceutical market.
In May 2013, Valeant built a factory for the production of drugs, which is one of the most modern in Europe. This is the largest Canadian greenfield investment in Serbia so far.
The projected production capacity is 16 million finished packages per year, while about 12 million are currently produced.
Today we employ 300 people and we are proud of each of them.